Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mix Vaccine in Metastatic Sarcoma
NCT03357315Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mix vaccine in sarcoma, sponsored by Fuda Cancer Hospital. Started Nov 2017; status: completed.
02
Drugs
mix vaccine
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT03357315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357315.